SCHEMBL23674279

SCHEMBL23674279

FC1(c2nc[nH]n2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23689691 0.72
SCHEMBL22380665 0.71
SCHEMBL19344897 0.68
SCHEMBL19344901 0.68 ADRA2A (0.30)
SCHEMBL32686473 0.66
SCHEMBL21293547 0.64
SCHEMBL32686538 0.61
SCHEMBL10531111 0.59
SCHEMBL23705835 0.55
SCHEMBL23706250 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230108442-A1 NOVEL ANTIMALARIAL AGENT CONTAINING HETEROCYCLIC COMPOUND EISAI R&D MANAGEMENT CO., LTD. (JP) 2023-04-06 US disclosed
US-20230108442-A1 NOVEL ANTIMALARIAL AGENT CONTAINING HETEROCYCLIC COMPOUND EISAI R&D MANAGEMENT CO., LTD. (JP) 2023-04-06 US disclosed
EP-4058147-A1 NOVEL ANTIMALARIAL AGENT CONTAINING HETEROCYCLIC COMPOUND Eisai R&D Management Co., Ltd (JP) 2022-09-21 EP disclosed
CN-114829351-A Novel antimalarial agents containing heterocyclic compounds 卫材R&D管理有限公司 2022-07-29 CN disclosed
WO-2021149692-A1 NOVEL ANTIMALARIAL AGENT CONTAINING HETEROCYCLIC COMPOUND EISAI R&D MANAGEMENT CO., LTD. (JP) 2021-07-29 WO disclosed
WO-2021149692-A1 NOVEL ANTIMALARIAL AGENT CONTAINING HETEROCYCLIC COMPOUND EISAI R&D MANAGEMENT CO., LTD. (JP) 2021-07-29 WO disclosed